Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Protein glue shows potential for use with biomaterials

  • Respiratory infection controls being used for Ebola patients are unnecessary, may contribute to public panic

  • Obese or overweight teens more likely to become smokers

  • Evidence mounting that older adults who volunteer are happier, healthier

  • Training your brain to prefer healthy foods

  • No cookie-cutter divorces, so what info should online co-parenting classes offer?

  • Healthy working environment is a salvation

  • Warm thanks: Gratitude can win you new friends

  • Learning to read: Tricking the brain

  • Meaningful relationships can help you thrive

  •